-
Overall, 39% of U.S. adults said they had “a great deal of confidence” in the scientific community, down from 48% in 2018 and 2021, according to the General Social Survey.
-
FDA scientific advisers reviewed whether the next round of shots should only include protection against the newest variants that are now dominant worldwide — a branch of the omicron family tree named XBB.
-
An AP analysis found that fraudsters potentially stole more than $280 billion in COVID-19 relief funding; another $123 billion was wasted or misspent. The loss represents 10 percent of the $4.2 trillion the U.S. government has disbursed in pandemic aid.
-
The White House said Jha will return to Brown University, where he had served as the dean of the university’s school of public health before joining the White House as its COVID-19 coordinator in April 2022.
-
The report shows early deaths among seniors are on the rise. Housing cost burdens are also among the highest in the nation.
-
The drug has been fully vetted by the U.S. government and can remain on the market indefinitely. Millions of Americans have received Paxlovid since it was granted emergency authorization in 2021.
-
Researchers identified a dozen key symptoms that help distinguish long COVID. They say doctors shouldn't use the list to diagnose patients — it's only a first step — but it might help future studies.
-
State data show that 10% of those who lost coverage were terminated because they were ineligible or hadn’t used Medicaid over the past 12 months. However, 82% of people lost coverage for procedural reasons.
-
The lawsuit is one of numerous cases filed in Florida and other states alleging that colleges and universities breached contracts and should be required to refund money to students.
-
Supreme Court Justice Neil Gorsuch's comments came in a statement that accompanied an order dismissing a case involving the use of the Title 42 policy to prevent asylum seekers from entering the country.